Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 16, 2022

SELL
$5.43 - $6.81 $1.79 Million - $2.25 Million
-330,000 Closed
0 $0
Q2 2021

Sep 21, 2023

BUY
$5.67 - $6.33 $1.87 Million - $2.09 Million
330,000 New
330,000 $1.92 Million
Q2 2021

Aug 20, 2021

SELL
$5.67 - $6.33 $185 Million - $207 Million
-32,670,000 Reduced 99.0%
330,000 $1.92 Million
Q2 2021

Aug 16, 2021

BUY
$5.67 - $6.33 $187 Million - $209 Million
33,000,000 New
33,000,000 $1.92 Million

Others Institutions Holding KMDA

About KAMADA LTD


  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $264M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.